Increased density of GABAA receptors in the superior temporal gyrus in schizophrenia
- PMID: 16362364
- DOI: 10.1007/s00221-005-0290-9
Increased density of GABAA receptors in the superior temporal gyrus in schizophrenia
Abstract
The superior temporal gyrus (STG) is strongly implicated in the pathophysiology of schizophrenia, particularly with regards to auditory hallucinations. In a previous study we reported a decrease in the density of M1 and M2/M4 muscarinic receptors in the STG in schizophrenia. In this study, we investigated the density of GABA(A) receptors in the left STG of schizophrenia patients compared to control subjects. We used quantitative autoradiography to investigate the binding of the agonist [(3)H] muscimol to GABA(A )receptors in the STG. A significantly higher density of [(3)H] muscimol binding was observed in the upper three quarters of the STG grey matter (corresponding to layers I-IV) than in the lower one-quarter (layers V-VI) in both groups. A significant increase (about 30%, P<0.05) in binding of [(3)H] muscimol was clearly observed in schizophrenia patients compared to control subjects. There were no significant correlations between [(3)H] muscimol binding density and age, post-mortem interval, brain pH or final recorded antipsychotic drug use. These results suggest an increase of GABA(A) receptor densities in the STG of schizophrenia patients.
Similar articles
-
Decreased density of serotonin 2A receptors in the superior temporal gyrus in schizophrenia--a postmortem study.Prog Neuropsychopharmacol Biol Psychiatry. 2009 Aug 1;33(5):867-71. doi: 10.1016/j.pnpbp.2009.04.010. Epub 2009 Apr 21. Prog Neuropsychopharmacol Biol Psychiatry. 2009. PMID: 19389456
-
Changes in hippocampal GABAA receptor subunit composition in bipolar 1 disorder.Brain Res Mol Brain Res. 2005 Aug 18;138(2):145-55. doi: 10.1016/j.molbrainres.2005.04.005. Brain Res Mol Brain Res. 2005. PMID: 15950312
-
Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia.Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):225-33. doi: 10.1016/j.pnpbp.2006.07.004. Epub 2006 Aug 9. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 16901598
-
Superior temporal gyrus in schizophrenia: a volumetric magnetic resonance imaging study.Schizophr Res. 2000 Jan 21;41(2):303-12. doi: 10.1016/s0920-9964(99)00083-3. Schizophr Res. 2000. PMID: 10708339 Review.
-
Abnormal neurochemical asymmetry in the temporal lobe of schizophrenia.Prog Neuropsychopharmacol Biol Psychiatry. 2001 May;25(4):867-77. doi: 10.1016/s0278-5846(01)00149-x. Prog Neuropsychopharmacol Biol Psychiatry. 2001. PMID: 11383982 Review.
Cited by
-
Molecular docking based screening of GABA (A) receptor inhibitors from plant derivatives.Bioinformation. 2015 Jun 30;11(6):280-9. doi: 10.6026/97320630011280. eCollection 2015. Bioinformation. 2015. PMID: 26229288 Free PMC article.
-
Altered gene expression in the superior temporal gyrus in schizophrenia.BMC Genomics. 2008 Apr 29;9:199. doi: 10.1186/1471-2164-9-199. BMC Genomics. 2008. PMID: 18445270 Free PMC article.
-
Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic location.PLoS One. 2011 Mar 1;6(3):e16886. doi: 10.1371/journal.pone.0016886. PLoS One. 2011. PMID: 21390302 Free PMC article.
-
In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophrenia.Neurosci Biobehav Rev. 2015 Apr;51:276-95. doi: 10.1016/j.neubiorev.2015.01.007. Epub 2015 Jan 19. Neurosci Biobehav Rev. 2015. PMID: 25614132 Free PMC article. Review.
-
Molecular mechanisms underlying synergistic effects of SSRI-antipsychotic augmentation in treatment of negative symptoms in schizophrenia.J Neural Transm (Vienna). 2009 Nov;116(11):1529-41. doi: 10.1007/s00702-009-0255-4. Epub 2009 Jul 4. J Neural Transm (Vienna). 2009. PMID: 19578925 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical